Skip Navigation
News and Publications
 
 
 
In This Section      
Print This Page

Promise and Progress - New Appointments and Arrivals

The Time is Now: 2010-2011

New Appointments and Arrivals

Date: November 11, 2010


Emmanuel Antonarakis, M.D.
1 2 3 4 5
Emmanuel Antonarakis, M.D.

Emmanuel S. Antonarakis, M.D., assistant professor of oncology, will focus on prostate cancer drug development and immunotherapy as a new addition to the genitourinary cancer program. He will use prognostic models of prostate cancer progression to design more informative clinical trials in men with localized or early relapsed prostate cancer.  He received American Society of Clinical Oncology Young Investigator Award for his translational clinical trial exploring itraconazole in metastatic castrate-resistant, or androgen-independent, prostate cancer.

Martin Aryee, Ph.D., is a new member of the Cancer Center’s emerging Quantitative Sciences Program and Division of Biostatistics and Bioinformatics.  He is a computational biologist focusing on molecular biology and cancer research and has developed analytical methods useful in cancer genetics and epigenetics research. Aryee also is a member of the Prostate Cancer Program. 
 
Christine H. Chung, M.D., associate professor of oncology, was selected in a national search to lead our Center’s clinical research  in head and neck cancer. She is studying EGFR inhibitors for the treatment of head and neck cancer. Chung also will be a collaborator in viral oncology research, researching the roles of the human papillomavirus (HPV) in the development of these cancers.  She co-chairs the Eastern Cooperative Oncology Group Correlative Science and Translational Research Program and holds a similar leadership role for the Radiation Therapy Oncology Group. She is a member the NCI’s tumor biology and imaging task force of the head and neck cancer steering committee.

Ana De Jesus-Acosta, M.D., instructor in oncology, is a new member of our gastrointestinal cancer program.  She will expand clinical research in pancreatic-biliary cancers and will focus on developing an early drug development clinical research program.

Nilanjan Ghosh, M.D., Ph.D., has joined the hematologic malignancies program as an instructor in oncology.  He will develop a clinical research program in multiple myeloma and lymphoma.

Matthias Holdhoff, M.D., Ph.D., assistant professor of oncology, has joined the Kimmel Cancer Center’s Brain Cancer Program and Ludwig Center for Caner Genetics and Therapeutics. For the last three years, he has trained under Stuart Grossman, M.D., and Luis Diaz, M.D.  As  a clinical investigator, he will focus on the development of blood-based tumor markers  and novel clinical trials for glioma and central nervous system(CNS) lymphoma.

Christian Meyer, M.D., Ph.D., instructor in oncology, has joined the Cancer Center faculty as the lead medical oncologist for the adult sarcoma and connective tissue oncology program. As a Kimmel Cancer Center fellow, Meyer was chief fellow of the Hematology and Medical Oncology training programs and, this year, received an American Society of Clinical Oncology Young Investigator Award.

Eric Schafer, M.D., instructor in oncology, is a new member of the pediatric oncology program.  In addition to his clinical work, he will be doing laboratory research with Patrick Brown, M.D., to develop clinical trials for children with MLL gene-rearranged leukemias.  Schafer competed and earned a spot in the Johns Hopkins Graduate Training Program in Clinical Investigation, and he was recently awarded a Young Investigator Award from Alex’s Lemonade Stand Foundation.

Robert Scharpf, Ph.D., has joined the Center’s Quantitative Sciences Program and Division of Biostatistics and Bioinformatics.  His current research focuses on the development of improved methodologies for analysis of genomewide biological data.  He will be taking a lead role in a reproducible research initiative aimed at providing tools that allow researchers easily share data and methods so that other scientists can reproduce and confirm their results.

Satish Shanbhag, M.D., M.P.H., has joined the Kimmel Cancer Center at Johns Hopkins Bayview as Clinical Director of Hematology. In addition to his training in oncology and hematology, Shanbhag holds Master of Public Health degree in health care organization and policy.

Related Content

Articles in this Issue

Director's Letter

 

Find Physicians Specializing In...

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer